Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]

Scaling production of adeno-associated virus vectors remains a key barrier [...]

Circio has raised NOK 250 million in a significantly oversubscribed [...]

Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

UMass Chan Medical School, Caring Cross and Trenchant BioSystems have [...]

BridgeBio Pharma has submitted a New Drug Application (NDA) to [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]